Novo Nordisk Targets 'Obesity Disease Market' Despite Commercial Doubts

Overweight stomach (shallow focus)
Diabetes Fighter Novo Nordisk Says It Will Increasingly Target Obesity • Source: Shutterstock

More from Strategy

More from Business